Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells

Jiang Chen1, Jie Ding2, Ziwei Wang1

  • 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Oncotarget
|January 26, 2017
PubMed
Abstract

Insights

Lysine-specific demethylase 1 (LSD1) regulates colon cancer metastasis by controlling CABYR and CDH1 gene expression. LSD1 depletion upregulates these genes via H3K4 methylation, while LSD1 overexpression downregulates them.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • Lysine-specific demethylase 1 (LSD1) is implicated in cancer progression.
  • Understanding LSD1's role in colon cancer metastasis is crucial for therapeutic development.

Purpose of the Study:

  • Identify downstream target genes of LSD1 in colon cancer cells.
  • Elucidate the molecular mechanisms by which LSD1 influences colon cancer invasion and metastasis.

Main Methods:

  • Gene expression profiling (microarray) was used to identify differentially expressed genes (DEGs) after LSD1 manipulation (siRNA and overexpression) in colon cancer cell lines.
  • Bioinformatic analysis (Gene Ontology, Pathway Studio) screened DEGs for roles in proliferation, metastasis, and invasion.
  • Quantitative PCR, Western blot, and ChIP assay validated target genes (CABYR, FOXF2, TLE4, CDH1) and LSD1's regulatory mechanism.

Main Results:

  • Thousands of DEGs were identified upon LSD1 silencing or overexpression.
  • LSD1 was confirmed as a negative regulator of CABYR and CDH1 expression.
  • LSD1's activity correlated with H3K4 methylation levels at target gene promoters.

Conclusions:

  • LSD1 depletion upregulates CABYR and CDH1 by enhancing H3K4 dimethylation at their promoters.
  • LSD1 overexpression downregulates CABYR and CDH1 by decreasing H3K4 methylation.
  • CABYR and CDH1 are potential LSD1 target genes in colon carcinogenesis.